PAVmed Inc.(PAVM)— Stock Profile, AI Score & Financials

Healthcare · Nasdaq · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated 2026-06-30.

PAVmed Inc. (PAVM) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores PAVM at 10.2/100 on a 32-signal composite quality model, placing it at rank #2,911 of 2,961 stocks — the bottom half of the AI-ranked universe. Based on the latest XBRL financial filings (Q2 2026), PAVmed Inc. reports quarterly revenue of $33.0K, net income of $-5.4M, free cash flow of $-2.7M. Top institutional holders of PAVM by reported 13-F value include Two Seas Capital, FIRST MANHATTAN, VANGUARD CAPITAL MANAGEMENT, based on the most recent SEC filings. PAVM trades on the Nasdaq exchange and files with the SEC under CIK 1624326. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate PAVM daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for PAVmed Inc. directly from SEC EDGAR.